Compounds > colistimethate sodium
Page last updated: 2024-09-05

colistimethate sodium and Kidney Failure, Chronic

colistimethate sodium has been researched along with Kidney Failure, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, G; Jitmuang, A; Koomanachai, P; Landersdorfer, CB; Lee, HJ; Li, J; Nation, RL; Sritippayawan, S; Thamlikitkul, V; Wasuwattakul, S2
Cardoso, DE; Carrilho, CM; Falci, DR; Levin, AS; Lopes, NT; Oliveira, MS; Perdigão-Neto, LV; Rigatto, MH; Tanita, MT; Tuon, FF; Zavascki, AP1

Other Studies

3 other study(ies) available for colistimethate sodium and Kidney Failure, Chronic

ArticleYear
Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1

    Topics: Anti-Bacterial Agents; Colistin; Humans; Kidney Failure, Chronic; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory

2014
Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:6

    Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Colistin; Female; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Models, Statistical; Prodrugs; Renal Dialysis; Time Factors; Urinalysis

2015
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Acute Kidney Injury; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Colistin; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Intraabdominal Infections; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Polymyxin B; Prospective Studies; Respiratory Tract Infections; Risk Factors; Survival Analysis

2016